Gilead (GILD) Up as Twice-Yearly HIV Shot Prevents Infection

Gilead Sciences, Inc. GILD announced upbeat top-line results from an interim analysis of its late-stage study PURPOSE 1. https://www.nasdaq.com/articles/gilead-gild-twice-yearly-hiv-shot-prevents-infection